EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 135 filers reported holding EPIZYME INC in Q2 2019. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,643,000 | -1.8% | 105,900 | +55.7% | 0.69% | +19.5% |
| Q4 2019 | $1,673,000 | +33.0% | 68,000 | -44.3% | 0.57% | +21.4% |
| Q3 2019 | $1,258,000 | -42.2% | 121,986 | -29.7% | 0.47% | -42.2% |
| Q2 2019 | $2,178,000 | +479.3% | 173,536 | +767.7% | 0.82% | +183.4% |
| Q1 2015 | $376,000 | – | 20,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |